简体
  • 简体中文
  • 繁体中文

热门资讯> 正文

Smith & Wesson Brands Posts Weak Q4 Results, Joins Aptevo Therapeutics And Other Big Stocks Moving Lower In Friday's Pre-Market Session

2025-06-20 20:01

U.S. stock futures were lower this morning, with the Dow futures falling around 0.2% on Friday.

Shares of Smith & Wesson Brands Inc (NASDAQ:SWBI) fell sharply in pre-market trading after the company reported worse-than-expected fourth-quarter EPS and sales.

Smith & Wesson Brands reported fourth-quarter revenue of $140.8 million, missing analyst estimates of $152.41 million, according to Benzinga Pro. The company reported adjusted earnings of 20 cents per share in the fourth quarter, missing estimates of 23 cents per share.

Smith & Wesson Brands shares dipped 12.6% to $9.51 in the pre-market trading session.

Here are some other stocks moving lower in pre-market trading.

  • Regencell Bioscience Holdings Ltd (NASDAQ:RGC) shares fell 16.2% to $52.96 in pre-market trading after dipping over 18% on Wednesday.
  • QuantaSing Group Ltd- ADR (NASDAQ:QSG) fell 12.1% to $11.86 in pre-market trading.
  • Aptevo Therapeutics Inc (NASDAQ:APVO) fell 11.9% to $4.52 in pre-market trading. Aptevo Therapeutics shares jumped 82% on Wednesday after the company announced clinical data from its ongoing Phase 1b/2 RAINIER trial evaluating mipletamig.
  • Capricor Therapeutics Inc (NASDAQ:CAPR) fell 7.4% to $11.04 in pre-market trading. Capricor Therapeutics recently announced Orphan Drug designation for Becker Muscular Dystrophy.
  • Mesoblast Ltd (NASDAQ:MESO) fell 6.5% to $10.94 in pre-market trading.
  • Diginex Limited (NASDAQ:DGNX) dropped 6.5% to $43.51 in pre-market trading.
  • Himalaya Shipping Ltd. (NASDAQ:HSHP) declined 6.3% to $6.22 in pre-market trading.
  • AIRO Group Holdings, Inc. (NASDAQ:AIRO) fell 5.3% to $24.88 in pre-market trading.

Now Read This:

  • Top 2 Industrials Stocks That May Fall Off A Cliff In Q2

Photo via Shutterstock

风险及免责提示:以上内容仅代表作者的个人立场和观点,不代表华盛的任何立场,华盛亦无法证实上述内容的真实性、准确性和原创性。投资者在做出任何投资决定前,应结合自身情况,考虑投资产品的风险。必要时,请咨询专业投资顾问的意见。华盛不提供任何投资建议,对此亦不做任何承诺和保证。